Back

Influence of pulmonary hypertension on the 6 and 12 months outcome in acutely decompensated heart failure patients.

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure - Clinical Clinical HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Amam Chinyere Mbakwem

College of Medicine University of Lagos, Lagos (Nigeria)

27 More presentations in this session

Presentation thumbnail
Prognostic impact of serum metabolomic profiling of patients with heart failure with reduced ejection fraction
Doctor R. Pistulli (Munster, DE)
Abstract
Presentation thumbnail
Left ventricular ejection fraction is unable to prognostic stratification in patients with chronic heart failure. the role of cardiopulmonary exercise test and right ventricular evaluation
Presentation thumbnail
Iron status and muscle-derived secretion of regenerative and pro-hypertrophic myokines (follistatin and decorin) in men with heart failure with reduced ejection fraction
Doctor M. Dziegala (Wroclaw, PL)
Abstract
Presentation thumbnail
Body composition and hydratation status in Heart Failure types
Doctor D. Gonzalez (Mexico City, MX)
Abstract
Presentation thumbnail
Abdominal obesity as risk factor for endothelial dysfunction in heart failure and chronic obstructive pulmonary disease
Professor G. Davila-Said (Mexico City, MX)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure - Clinical

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Presentation
Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources